Literature DB >> 17177076

Rotigotine transdermal system for perioperative administration.

A D Korczyn1, H Reichmann, B Boroojerdi, H-J Häck.   

Abstract

We present a series of patients participating in clinical trials with the rotigotine transdermal system. All patients were scheduled for surgery with general anaesthesia unrelated to the trial procedure or to rotigotine. Perioperative administration of rotigotine appeared to be feasible and efficacious. No safety issues emerged from these observations.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17177076     DOI： 10.1007/s00702-006-0606-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  12 in total

1.  Postoperative complications in Parkinson's disease.

Authors:  P V Pepper; M K Goldstein
Journal:  J Am Geriatr Soc       Date:  1999-08       Impact factor: 5.562

2.  Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery.

Authors:  E Broussolle; M H Marion; P Pollak
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

3.  [Incidence of operations in Germany via telephone survey in 4 selected cities].

Authors:  R Weitkunat; O Sangha; A Crispin; C Ohmann; M Wildner
Journal:  Gesundheitswesen       Date:  2000-07

4.  Acute akinesia or akinetic crisis in Parkinson's disease.

Authors:  A Thomas; D Iacono; A L Luciano; K Armellino; M Onofrj
Journal:  Neurol Sci       Date:  2003-10       Impact factor: 3.307

Review 5.  Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis.

Authors:  J Kornhuber; M Weller; P Riederer
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1993

6.  Prevalence of movement disorders in elderly community residents.

Authors:  S Moghal; A H Rajput; C D'Arcy; R Rajput
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

Review 7.  Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome.

Authors:  M A Granner; G F Wooten
Journal:  Semin Neurol       Date:  1991-09       Impact factor: 3.420

8.  Parkinsonism with 'on-off' phenomena. Intravenous treatment with levodopa after major abdominal surgery.

Authors:  A J Rosin; D Devereux; N Eng; D B Calne
Journal:  Arch Neurol       Date:  1979-01

Review 9.  Movement disorder emergencies in the perioperative period.

Authors:  Steven J Frucht
Journal:  Neurol Clin       Date:  2004-05       Impact factor: 3.806

Review 10.  The perioperative management of Parkinson's disease revisited.

Authors:  Néstor Gálvez-Jiménez; Anthony E Lang
Journal:  Neurol Clin       Date:  2004-05       Impact factor: 3.806
View more
  6 in total

Review 1.  Medication adherence in patients with Parkinson's disease.

Authors:  Naveed Malek; Donald G Grosset
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

2.  Transdermal rotigotine for the perioperative management of Parkinson's disease.

Authors:  Ullrich Wüllner; Jan Kassubek; Per Odin; Michael Schwarz; Markus Naumann; Hermann-Josef Häck; Babak Boroojerdi; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

Review 3.  [Pharmacological treatment of motor symptoms in Parkinson's diseases].

Authors:  W H Jost
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 4.  Clinical problems in the hospitalized Parkinson's disease patient: systematic review.

Authors:  Oliver H H Gerlach; Ania Winogrodzka; Wim E J Weber
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

5.  Interventions to minimize complications in hospitalized patients with Parkinson disease.

Authors:  Sana Aslam; Edith Simpson; Matthew Baugh; Holly Shill
Journal:  Neurol Clin Pract       Date:  2020-02

6.  Transdermal rotigotine for the perioperative management of restless legs syndrome.

Authors:  Birgit Högl; Wolfgang H Oertel; Erwin Schollmayer; Lars Bauer
Journal:  BMC Neurol       Date:  2012-09-25       Impact factor: 2.474
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.